The diagnostic and therapeutic challenges of Grade 3B follicular lymphoma

Allison Barraclough, Mark Bishton, Chan Y. Cheah, Diego Villa, Eliza A. Hawkes

Research output: Contribution to journalReview articlepeer-review

10 Citations (Scopus)


Grade 3B follicular lymphoma (G3B FL) is rare, accounting for only 5–10% of FLs. Not only has it been routinely excluded from clinical trials, but data published on diagnosis, outcomes, choice of therapies and role of imaging are conflicting. With the advent of increasingly diverse treatment options for low-grade (G1–3A) FL, and the molecular subcategorisation of high-grade B-cell lymphomas, characterisation and treatment of G3B FL is ever more important as extrapolation of data becomes more difficult. New data have emerged exploring unique genetic characteristics, specific features on positron emission tomography imaging, choice of therapy, and outcomes of G3B FL in the current era. The present review will summarise and appraise these new data, and offer recommendations based on current evidence.

Original languageEnglish
Pages (from-to)15-24
Number of pages10
JournalBritish Journal of Haematology
Issue number1
Early online date11 Mar 2021
Publication statusPublished - Oct 2021


Dive into the research topics of 'The diagnostic and therapeutic challenges of Grade 3B follicular lymphoma'. Together they form a unique fingerprint.

Cite this